A Feasibility Study to Evaluate the Clinical Performance and Safety of the VITA AV Clinical System When Used for the Treatment of Vaginal Atrophy

Unknown Not Applicable NCT06207227

Study Description

The primary objective of this clinical investigation is to demonstrate that treatment with the VITA AV clinical system is feasible and to evaluate clinical performance and safety when used to improve the symptoms and signs of vaginal atrophy (VA) due to menopause.

Study Details

Registry ID:
NCT06207227
Conditions:
Vaginal Atrophy
Phase:
Not Applicable
Target Enrollment:
12 participants
Start Date:
Age Range:
51–70 years
Gender:
Female
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →